AKBA Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Akebia Therapeutics Inc

Watchlist Manager

Watchlist

Price: 1.24 USD 2.48% Market Closed

Market Cap: $332.6m

	Akebia Therapeutics Inc NASDAQ:AKBA	US
	Nissan Chemical Corp OTC:NNCHF	JP
B	Boston Beer Company Inc F:BBEA	US
B	Boston Beer Company Inc SWB:BBEA	US
G	Globe Life Inc F:TMJ	US
F	Frasers Property Thailand Industrial Freehold & Leasehold REIT SET:FTREIT	TH
	Capital Ltd F:C8D	UK
	Fuelcell Energy Inc NASDAQ:FCEL	US
O	Ovintiv Inc TSX:OVV	US
D	Deluxe Corp XMUN:DL8	US

Profitability Summary

Akebia Therapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

79%

Strong 3Y Average Gross Margin

83%

Declining Gross Margin

80% > 79%

Low Operating Margin

Negative 3Y Average Operating Margin

-14%

Operating Margin is Increasing

-46% > 2%

Negative Net Margin

-9%

Negative 3Y Average Net Margin

-24%

Net Margin is Increasing

-51% > -9%

Exceptional Free Cash Flow Margin

22%

Negative 3Y Average Free Cash Flow Margin

-9%

Free Cash Flow Margin is Increasing

-17% > 22%

Negative ROE

-79%

Exceptional 3Y Average ROE

Negative 3Y Average ROIC

-11%

ROIC is Increasing

-34% > 3%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.